BridgeMD
New treatment option for Stroke
Official title Improving Participation After Stroke Self-Management-Rehabilitation
ClinicalTrials.gov ID: NCT06588647
What this study is testing
- What it's testing
- The overall goal of this proposed study is to evaluate the efficacy of a small-group, stroke-specific, self-management program delivered via telehealth to improve self-efficacy, activity performance, and quality of life in individuals with sub-acute stroke.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 85
You may be able to join if
- less than 6 months post-stroke
- age 45-85 years
- completed inpatient rehabilitation services (if recommended)
- living in the community with or without caregiver support (i.e., not living in a skilled nursing facility)
- ability to read, write, and speak English
You likely can't join if
- severe depressive symptoms as indicated by a score ≥21 on the Patient Health Questionnaire
- dementia symptoms as indicated by a score of \<23 on the Montreal Cognitive Assessment
- additional neurological diagnoses (e.g., brain malignancy, previous severe stroke)
- (4) moderate or severe aphasia as indicated by a National Institutes of Health Stroke Scale aphasia score of ≥ 2
- inability to provide informed consent
- any other condition not otherwise specified that the PI determines would render participation in this study as unsafe for the participant
See the full eligibility criteria
- less than 6 months post-stroke
- age 45-85 years
- completed inpatient rehabilitation services (if recommended)
- living in the community with or without caregiver support (i.e., not living in a skilled nursing facility)
- ability to read, write, and speak English
- diagnosis of mild or moderate stroke (National Institutes of Health stroke score \<16)
- able to use videoconferencing independently or with caregiver support
- severe depressive symptoms as indicated by a score ≥21 on the Patient Health Questionnaire
- dementia symptoms as indicated by a score of \<23 on the Montreal Cognitive Assessment
- additional neurological diagnoses (e.g., brain malignancy, previous severe stroke)
- (4) moderate or severe aphasia as indicated by a National Institutes of Health Stroke Scale aphasia score of ≥ 2
- inability to provide informed consent
- any other condition not otherwise specified that the PI determines would render participation in this study as unsafe for the participant
The study team makes the final eligibility decision.
Where it's taking place
- Columbia, Missouri, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Columbia, Missouri, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.